v3.22.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (48,956) $ (322,722)
Reconciling items:    
Depreciation 50,760 56,975
Amortization 49,709 51,901
Amortization of non-recoupable ticketing contract advances 18,527 10,621
Amortization of debt issuance costs and discounts 4,114 9,196
Non-cash compensation expense 49,241 40,017
Unrealized changes in fair value of contingent consideration 10,904 (9,440)
Gain (Loss) on Sale of Investments (132) 53,899
Other, net 7,500 2,921
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions:    
Decrease (increase) in accounts receivable (152,725) 21,861
Decrease (increase) in prepaid expenses and other assets (338,017) 4,704
Increase (decrease) in accounts payable, accrued expenses and other liabilities 236,584 (39,044)
Increase in deferred revenue 1,310,527 301,483
Net cash provided by operating activities 1,198,300 74,574
CASH FLOWS FROM INVESTING ACTIVITIES    
Advances of notes receivable (18,399) (10,784)
Collections of notes receivable 6,709 884
Investments made in nonconsolidated affiliates (26,243) (5,506)
Purchases of property, plant and equipment (62,525) (23,763)
Cash paid for acquisitions, net of cash acquired (13,962) (6,132)
Proceeds from Sale of Long-term Investments 332 60,308
Other, net (865) (4,899)
Net cash provided by (used in) investing activities (114,953) 10,108
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from long-term debt, net of debt issuance costs 700 501,366
Payments on long-term debt (12,784) (80,316)
Contributions from noncontrolling interests 5,712 1,722
Distributions to noncontrolling interests (38,966) (5,616)
Proceeds from exercise of stock options 10,907 25,794
Taxes paid for net share settlement of equity awards (36,568) (19,944)
Other, net (4,042) (5,989)
Net cash provided by (used in) financing activities (75,041) 417,017
Effect of exchange rate changes on cash, cash equivalents and restricted cash (21,079) (30,681)
Net increase in cash, cash equivalents, and restricted cash 987,227 471,018
Cash, cash equivalents, and restricted cash at beginning of period 4,887,792 2,546,439
Cash, cash equivalents, and restricted cash at end of period $ 5,875,019 $ 3,017,457

Source